Evidence map›Paper›PMID 37636936›Full record

ArticleACS omega2023

Molecular Insights into the

Abid Ali Ahmad, Kashif Hussain, Muhammad Raza Shah, Syed Muhammad Ashhad Halimi, Fazle Rabbi, Zahoor Ahmad, Inamullah Khan, Abdur Rauf, Abdulrahman Alshammari, Metab Alharbi and 1 more

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Abid Ali AhmadDepartment of Pharmacy, University of Peshawar, Peshawar, Khyber Pakhtunkhwa 25120, Pakistan.
Kashif HussainHEJ, Research Institute of Chemistry, ICCBS, University of Karachi, Karachi, Sindh 75270, Pakistan.
Muhammad Raza ShahHEJ, Research Institute of Chemistry, ICCBS, University of Karachi, Karachi, Sindh 75270, Pakistan.
Syed Muhammad Ashhad HalimiDepartment of Pharmacy, University of Peshawar, Peshawar, Khyber Pakhtunkhwa 25120, Pakistan.
Fazle RabbiDepartment of Pharmacy, Abasyn University Peshawar, Peshawar, Khyber Pakhtunkhwa 25000, Pakistan.
Zahoor AhmadDepartment of Pharmacy, University of Peshawar, Peshawar, Khyber Pakhtunkhwa 25120, Pakistan.
Inamullah KhanDepartment of Pharmacy, University of Peshawar, Peshawar, Khyber Pakhtunkhwa 25120, Pakistan.
Abdur RaufDepartment of Chemistry, University of Swabi, Swabi, Anbar, Khyber Pakhtunkhwa 23561, Pakistan.ORCID https://orcid.org/0000-0003-2429-5491
Abdulrahman AlshammariDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia.
Metab AlharbiDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia.
Hafiz Ansar Rasul SuleriaSchool of Agriculture and Food, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, Victoria 3010, Australia.
University of Peshawar · PKKing Saud University · SAUniversity of Karachi · PKAbasyn University · PKThe University of Melbourne · AUUniversity of Swabi · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The primary objective of this research was to identify and explore the most potent and efficacious cyclooxygenase inhibitors, utilizing indole acetic acid drugs as a lead molecule. To achieve this objective, various derivatives (

Identifiers

PMID37636936
PMCPMC10448495
OpenAlexW4385739778

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.